Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus

    Research output: Contribution to journalArticle

    75 Citations (Scopus)

    Abstract

    The role of cortisol in regulating cardiac myocyte growth in the near-term fetal sheep is unknown. We hypothesized that cortisol would suppress cardiomyocyte proliferation and stimulate cardiomyocyte binucleation and enlargement, signs of terminal differentiation. Cardiomyocyte dimensions and percent binucleation were determined in isolated cardiac myocytes from seven cortisol-treated and seven control fetuses; percentage of myocytes positive for Ki-67 was determined in an additional four cortisol-treated and four control hearts. Cortisol was infused into the circumflex coronary artery at subpressor rates (0.5 μg/kg·min, 7 d). Cortisol infusion had no hemodynamic effects, compared with controls or pretreatment conditions. Cortisol treatment increased heart weight (44.0 ± 8.7 g vs. control, 34.9 ± 9.1 g, P <0.05). Heart to body weight ratio was greater in treated hearts, compared with controls (10.3 ± 1.9 vs. 7.7 ± 0.9 g/kg, P <0.01). Ventricular myocyte length, width, and percent binucleation were not different between groups. The proportion of treated myocytes in the cell cycle staining for Ki-67 was higher in the left ventricle (5.5 ± 0.1 vs. 2.7 ± 0.4%, P <0.005) and right ventricle (4.4 ± 0.4 vs. 3.7 ± 0.7%, P <0.05), compared with controls. Wet weight to dry weight ratios from cortisol-treated and control hearts were not different. In conclusion, whereas cortisol infused into the fetal sheep heart has no effect on cardiomyocyte size or maturational state, it stimulates entry of cardiomyocytes in the cell cycle. Thus, increases in fetal heart mass associated with subpressor doses of cortisol are due to cardiomyocyte proliferation and not hypertrophic growth.

    Original languageEnglish (US)
    Pages (from-to)3643-3649
    Number of pages7
    JournalEndocrinology
    Volume147
    Issue number8
    DOIs
    StatePublished - 2006

    Fingerprint

    Cardiac Myocytes
    Hydrocortisone
    Sheep
    Cell Cycle
    Fetus
    Muscle Cells
    Fetal Heart
    Weights and Measures
    Heart Ventricles
    Growth
    Coronary Vessels
    Hemodynamics
    Body Weight
    Staining and Labeling

    ASJC Scopus subject areas

    • Endocrinology
    • Endocrinology, Diabetes and Metabolism

    Cite this

    Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus. / Giraud, George; Louey, Samantha; Jonker, Sonnet; Schultz, J.; Thornburg, Kent.

    In: Endocrinology, Vol. 147, No. 8, 2006, p. 3643-3649.

    Research output: Contribution to journalArticle

    @article{827f741108a54ff39f4d6f1315381b83,
    title = "Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus",
    abstract = "The role of cortisol in regulating cardiac myocyte growth in the near-term fetal sheep is unknown. We hypothesized that cortisol would suppress cardiomyocyte proliferation and stimulate cardiomyocyte binucleation and enlargement, signs of terminal differentiation. Cardiomyocyte dimensions and percent binucleation were determined in isolated cardiac myocytes from seven cortisol-treated and seven control fetuses; percentage of myocytes positive for Ki-67 was determined in an additional four cortisol-treated and four control hearts. Cortisol was infused into the circumflex coronary artery at subpressor rates (0.5 μg/kg·min, 7 d). Cortisol infusion had no hemodynamic effects, compared with controls or pretreatment conditions. Cortisol treatment increased heart weight (44.0 ± 8.7 g vs. control, 34.9 ± 9.1 g, P <0.05). Heart to body weight ratio was greater in treated hearts, compared with controls (10.3 ± 1.9 vs. 7.7 ± 0.9 g/kg, P <0.01). Ventricular myocyte length, width, and percent binucleation were not different between groups. The proportion of treated myocytes in the cell cycle staining for Ki-67 was higher in the left ventricle (5.5 ± 0.1 vs. 2.7 ± 0.4{\%}, P <0.005) and right ventricle (4.4 ± 0.4 vs. 3.7 ± 0.7{\%}, P <0.05), compared with controls. Wet weight to dry weight ratios from cortisol-treated and control hearts were not different. In conclusion, whereas cortisol infused into the fetal sheep heart has no effect on cardiomyocyte size or maturational state, it stimulates entry of cardiomyocytes in the cell cycle. Thus, increases in fetal heart mass associated with subpressor doses of cortisol are due to cardiomyocyte proliferation and not hypertrophic growth.",
    author = "George Giraud and Samantha Louey and Sonnet Jonker and J. Schultz and Kent Thornburg",
    year = "2006",
    doi = "10.1210/en.2006-0061",
    language = "English (US)",
    volume = "147",
    pages = "3643--3649",
    journal = "Endocrinology",
    issn = "0013-7227",
    publisher = "The Endocrine Society",
    number = "8",

    }

    TY - JOUR

    T1 - Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus

    AU - Giraud, George

    AU - Louey, Samantha

    AU - Jonker, Sonnet

    AU - Schultz, J.

    AU - Thornburg, Kent

    PY - 2006

    Y1 - 2006

    N2 - The role of cortisol in regulating cardiac myocyte growth in the near-term fetal sheep is unknown. We hypothesized that cortisol would suppress cardiomyocyte proliferation and stimulate cardiomyocyte binucleation and enlargement, signs of terminal differentiation. Cardiomyocyte dimensions and percent binucleation were determined in isolated cardiac myocytes from seven cortisol-treated and seven control fetuses; percentage of myocytes positive for Ki-67 was determined in an additional four cortisol-treated and four control hearts. Cortisol was infused into the circumflex coronary artery at subpressor rates (0.5 μg/kg·min, 7 d). Cortisol infusion had no hemodynamic effects, compared with controls or pretreatment conditions. Cortisol treatment increased heart weight (44.0 ± 8.7 g vs. control, 34.9 ± 9.1 g, P <0.05). Heart to body weight ratio was greater in treated hearts, compared with controls (10.3 ± 1.9 vs. 7.7 ± 0.9 g/kg, P <0.01). Ventricular myocyte length, width, and percent binucleation were not different between groups. The proportion of treated myocytes in the cell cycle staining for Ki-67 was higher in the left ventricle (5.5 ± 0.1 vs. 2.7 ± 0.4%, P <0.005) and right ventricle (4.4 ± 0.4 vs. 3.7 ± 0.7%, P <0.05), compared with controls. Wet weight to dry weight ratios from cortisol-treated and control hearts were not different. In conclusion, whereas cortisol infused into the fetal sheep heart has no effect on cardiomyocyte size or maturational state, it stimulates entry of cardiomyocytes in the cell cycle. Thus, increases in fetal heart mass associated with subpressor doses of cortisol are due to cardiomyocyte proliferation and not hypertrophic growth.

    AB - The role of cortisol in regulating cardiac myocyte growth in the near-term fetal sheep is unknown. We hypothesized that cortisol would suppress cardiomyocyte proliferation and stimulate cardiomyocyte binucleation and enlargement, signs of terminal differentiation. Cardiomyocyte dimensions and percent binucleation were determined in isolated cardiac myocytes from seven cortisol-treated and seven control fetuses; percentage of myocytes positive for Ki-67 was determined in an additional four cortisol-treated and four control hearts. Cortisol was infused into the circumflex coronary artery at subpressor rates (0.5 μg/kg·min, 7 d). Cortisol infusion had no hemodynamic effects, compared with controls or pretreatment conditions. Cortisol treatment increased heart weight (44.0 ± 8.7 g vs. control, 34.9 ± 9.1 g, P <0.05). Heart to body weight ratio was greater in treated hearts, compared with controls (10.3 ± 1.9 vs. 7.7 ± 0.9 g/kg, P <0.01). Ventricular myocyte length, width, and percent binucleation were not different between groups. The proportion of treated myocytes in the cell cycle staining for Ki-67 was higher in the left ventricle (5.5 ± 0.1 vs. 2.7 ± 0.4%, P <0.005) and right ventricle (4.4 ± 0.4 vs. 3.7 ± 0.7%, P <0.05), compared with controls. Wet weight to dry weight ratios from cortisol-treated and control hearts were not different. In conclusion, whereas cortisol infused into the fetal sheep heart has no effect on cardiomyocyte size or maturational state, it stimulates entry of cardiomyocytes in the cell cycle. Thus, increases in fetal heart mass associated with subpressor doses of cortisol are due to cardiomyocyte proliferation and not hypertrophic growth.

    UR - http://www.scopus.com/inward/record.url?scp=33746080385&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=33746080385&partnerID=8YFLogxK

    U2 - 10.1210/en.2006-0061

    DO - 10.1210/en.2006-0061

    M3 - Article

    C2 - 16690807

    AN - SCOPUS:33746080385

    VL - 147

    SP - 3643

    EP - 3649

    JO - Endocrinology

    JF - Endocrinology

    SN - 0013-7227

    IS - 8

    ER -